CIBC World Markets »

Lineage Cell Therapeutics In shares owned by CIBC World Markets

Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by CIBC World Markets from 13F filings

Historical chart of CIBC World Markets investment in Lineage Cell Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including Lineage Cell Therapeutics In held by CIBC World Markets consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lineage Cell Therapeutics In by CIBC World Markets

Quarter filed Position value Share count Share price at filing
2024-03-31 $68k 46k 1.48
2023-09-30 $54k 46k 1.17

More positions owned by CIBC World Markets

Rbc Cad (RY)
Toronto Dominion Bk Ont Com New (TD)
Bk Nova Cad (BNS)
Bank Of Montreal Cadcom (BMO)
Shopify Cl A (SHOP)
Tc Energy Corp (TRP)
Canadian Natural Resources (CNQ)
Suncor Energy (SU)
Enbridge (ENB)
NVIDIA Corporation (NVDA)
Cibc Cad (CM)
Select Sector Spdr Tr Financial (XLF)
Microsoft Corporation (MSFT)
Manulife Finl Corp (MFC)
Canadian Natl Ry (CNI)

View all positions for CIBC World Markets

Top funds holding Lineage Cell Therapeutics In

BlackRock
Vanguard Group
Logos Global Management
Defender Capital
Geode Capital Management
Raffles Associates
Prescott General Partners
MAI Wealth Advisors
DAFNA Capital Management
Bank of America Corporation
Northern Trust
Bridgeway Capital Management
Jpmorgan Chase & Co
Nuveen Asset Management
Morgan Stanley

View all funds holding Lineage Cell Therapeutics In